Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for sedation and hemodynamics during colonoscopy
ChiCTR2200062667Phase 4Not yet recruiting
- Sponsor
- Zhuji People's Hospital of Zhejiang Province
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol (2 arms), sponsored by Zhuji People's Hospital of Zhejiang Province. Primary endpoints: Feasibility of performing colonoscopy and Sedation effectiveness. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2200062667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062667.